Wixela vs Combivent
What to choose Wixela or Combivent
Wixela is inhaler of type Control while Combivent is of Rescue type. Wixela and Combivent are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Combivent is manufactured by Boehringer Ingelheim. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Combivent are Ipratropium and Albuterol. The available dosage for Combivent is 20/100.
The current cost for Wixela is around $240 while average cost for Combivent is approximately $397, said Frank Price, an Adjunct Professor at the Chapman University and an Advanced Medical Support Assistant at a clinic that uses Wixela and Combivent.
Wixela and Combivent Comparison
| Wixela | Combivent | |
|---|---|---|
| Type: | Control | Rescue |
| Manufacturer: | Viatris | Boehringer Ingelheim |
| Substance: | Fluticasone + Salmeterol | Ipratropium + Albuterol |
| Dosage: | 250/50 | 20/100 |
| Avg Price: | $240 | $397 |